STOCKWATCH
·
Pharmaceuticals
Quarterly Updates13 May 2026, 12:57 pm

Cipla FY26 Revenue at ₹28,163 Cr, Up YoY

AI Summary

Cipla Ltd announced its audited consolidated financial results for Q4 and FY 2025-26. FY26 revenue reached ₹28,163 Cr, the highest ever, with the One-India business surpassing ₹12,500 Cr. North America delivered $780 Mn in annual revenue, and Emerging Markets and Europe exceeded $400 Mn. Q4 revenue stood at ₹6,541 Cr with a PAT of ₹555 Cr. R&D investments were ₹509 Cr, representing 7.8% of sales for the quarter. The company holds a net cash position of ₹10,526 Cr.

Key Highlights

  • Cipla's FY26 revenue reached a record ₹28,163 Cr.
  • One-India business exceeded ₹12,500 Cr in annual revenue.
  • North America delivered $780 Mn in annual revenue.
  • Q4 revenue was ₹6,541 Cr with a PAT of ₹555 Cr.
  • Net cash position stands at ₹10,526 Cr.
CIPLA
Pharmaceuticals
CIPLA LTD.

Price Impact